Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
Identifieur interne : 001B10 ( Main/Exploration ); précédent : 001B09; suivant : 001B11Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
Auteurs : Mahmud Tareq Hassan Khan [Norvège, Bangladesh]Source :
- Topics in Heterocyclic Chemistry [ 1861-9282 ]
Abstract
Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.
Url:
DOI: 10.1007/7081_2007_087
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B42
- to stream Istex, to step Curation: 000B42
- to stream Istex, to step Checkpoint: 000993
- to stream Main, to step Merge: 001B21
- to stream Main, to step Curation: 001B10
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><author><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E321B47C791B292DD530740F5E0888E20ACF93F8</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1007/7081_2007_087</idno><idno type="url">https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000B42</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B42</idno><idno type="wicri:Area/Istex/Curation">000B42</idno><idno type="wicri:Area/Istex/Checkpoint">000993</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000993</idno><idno type="wicri:doubleKey">1861-9282:2007:Khan M:quinoline:analogs:as</idno><idno type="wicri:Area/Main/Merge">001B21</idno><idno type="wicri:Area/Main/Curation">001B10</idno><idno type="wicri:Area/Main/Exploration">001B10</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><author><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>School of Molecular and Structural Biology, and Department of Pharmacology, Institute of Medical Biology, University of Tromsø, 9037, Tromsø</wicri:regionArea><wicri:noRegion>Tromsø</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Bangladesh</country><wicri:regionArea>Pharmacology Research Lab., Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong</wicri:regionArea><wicri:noRegion>Chittagong</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Norvège</country></affiliation></author></analytic><monogr></monogr><series><title level="s" type="main" xml:lang="en">Topics in Heterocyclic Chemistry</title><idno type="ISSN">1861-9282</idno><idno type="eISSN">1861-9290</idno><idno type="ISSN">1861-9282</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1861-9282</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.</div></front></TEI><affiliations><list><country><li>Bangladesh</li><li>Norvège</li></country></list><tree><country name="Norvège"><noRegion><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name></noRegion><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name></country><country name="Bangladesh"><noRegion><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E321B47C791B292DD530740F5E0888E20ACF93F8
|texte= Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
}}
| This area was generated with Dilib version V0.6.33. |  |